| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/04/2003 | US20030166600 An isolated polynucleotide encoding the proteins, receptor binding assay, drug screening, culturing, kits for analyzing; treating obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, schizophrenia |
| 09/04/2003 | US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide |
| 09/04/2003 | US20030166530 Conjugate heat shock protein-binding peptides |
| 09/04/2003 | US20030166286 Chimeric adenoviral fiber protein and methods of using same |
| 09/04/2003 | US20030166278 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| 09/04/2003 | US20030166274 Three-dimensional matrix for producing living tissue equivalents |
| 09/04/2003 | US20030166273 Culturing in a medium containing vascular endothelial cell growth factor, fibroblast growth factor, insulin-like growth factor and epidermal growth factor; inducing blood vessel formation when transplanted in vivo |
| 09/04/2003 | US20030166272 Contacting a committed cell with an antibody to retrodifferentiate; therapeutic treatment of an immunological disorder or disease; stem cells |
| 09/04/2003 | US20030166271 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy |
| 09/04/2003 | US20030166257 Use of Lactobacillus salivarius |
| 09/04/2003 | US20030166254 Moving promoter distal gene toward a wild-type 3' gene; gene mapping, genetic engineering; an attenuated virus useful for a vaccine |
| 09/04/2003 | US20030166253 A simple and efficient method of producing mammalian reovirus is developed using HEK 293 cells. The method provides for fast production of reovirus in high yield. Furthermore, this method provides for a simpler purification procedure of the |
| 09/04/2003 | US20030166140 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide polyadenylation sequence all |
| 09/04/2003 | US20030166097 Comprises nucleotide sequences coding membrane proteins for use diagnosing, treating and preventing autoimmune, inflammatory, viral, infectious and cancer diseases |
| 09/04/2003 | US20030166029 Obtaining an inhibitor of antibody-mediated lipid oxidation; drug screening; hemolysis; anticholesterol agents; cardiovascular disorder therapy |
| 09/04/2003 | US20030166022 Polypeptide for detecting and treating cancer; genetic vaccine |
| 09/04/2003 | US20030165907 Human glycine transporter type 2 |
| 09/04/2003 | US20030165574 Compositions and methods for treatment of body weight conditions |
| 09/04/2003 | US20030165573 Purification of red blood cells by separation and diafiltration |
| 09/04/2003 | US20030165492 Administering Dna sequences; genetic engineering |
| 09/04/2003 | US20030165484 Stem cells and signals developed for use in tissue and organ repair and replacement |
| 09/04/2003 | US20030165482 Skin disorders; wound healing agents; antiscarring agents |
| 09/04/2003 | US20030165480 Using swine organs; controlling gene expression |
| 09/04/2003 | US20030165474 Urinary tract tissue graft compositions and methods for producing same |
| 09/04/2003 | US20030165473 Mixture of Dna, glycoprotein and collagen |
| 09/04/2003 | US20030165466 Recombinant poliovirus for the treatment of cancer |
| 09/04/2003 | US20030165465 Treatment of neoplasms with viruses |
| 09/04/2003 | US20030165464 In vivo stimulation of angiogenic activity |
| 09/04/2003 | US20030165463 Enhanced system for construction of adenovirus vectors |
| 09/04/2003 | DE20306600U1 Pharmaceutical product, useful for skin or wound care, comprises an ointment base containing a tincture of poplar bud resin combined with milk fat or another carrier |
| 09/04/2003 | CA2513190A1 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 09/04/2003 | CA2476994A1 Methods of extending corneal graft survival |
| 09/04/2003 | CA2476571A1 Method for isolating ligands |
| 09/04/2003 | CA2467833A1 Pharmaceutical compositions in particulate form |
| 09/03/2003 | EP1340506A1 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties |
| 09/03/2003 | EP1339862A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 09/03/2003 | EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof |
| 09/03/2003 | EP1339833A1 Dehydrated antigen presenting cells usable for vaccination |
| 09/03/2003 | EP1339831A1 In vitro synthesis of a layered cell sorted tissue |
| 09/03/2003 | EP1339738A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/03/2003 | EP1339736A2 Oncolytic virus |
| 09/03/2003 | EP1339735A1 Method for preparing tryptophan rich peptides |
| 09/03/2003 | EP1339440A1 An implantable or insertable therapeutic agent delivery device |
| 09/03/2003 | EP1339419A1 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa |
| 09/03/2003 | EP1339356A2 Tissue-engineered vascular structures |
| 09/03/2003 | EP1339349A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 09/03/2003 | EP1339294A1 Nutritional composition for an immune condition |
| 09/03/2003 | EP0927195B1 Process for producing a plasma protein-containing medicament |
| 09/03/2003 | EP0841943B1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 09/03/2003 | EP0763116B1 Recombinant viruses, preparation and use thereof in gene therapy |
| 09/03/2003 | CN1440414A Synthesis of cuttlefish compound |
| 09/03/2003 | CN1440299A Method for producing bio-artificial transplant |
| 09/03/2003 | CN1440297A photodynamic treatment and UV-B irradiation of thrombocyte suspension |
| 09/03/2003 | CN1440295A Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol monno-oligosaccharide |
| 09/03/2003 | CN1440279A Delivery mechanism for introduction of biological substances to animals |
| 09/03/2003 | CN1439663A Method for extracting and purifying cartilage style proteoglycan |
| 09/03/2003 | CN1439424A Anti-SARS virus transfer factor preparation method |
| 09/03/2003 | CN1439418A Auxiliary medicine for cancer and preparation thereof |
| 09/03/2003 | CN1439412A Drug and preparation method for improvement of organismic immunity |
| 09/03/2003 | CN1439405A External used medicine against piles |
| 09/03/2003 | CN1439381A Separating method, medicinal use and preparation of medicinal components of anaerobic corynebacterium parvum |
| 09/03/2003 | CN1439380A Degradable apisin microballoons injection and preparation thereof |
| 09/03/2003 | CN1439379A Use of salivary gland secreta of cyclostomata in preparing medicines |
| 09/03/2003 | CN1120017C Tendon injure treating spray and its preparation |
| 09/03/2003 | CN1120015C High-efficient pure natural hypoglycemic agent |
| 09/03/2003 | CN1120014C Chinese patent medicine for treating hyperosteogeny |
| 09/03/2003 | CN1120010C Scrophularia capsule and its preparing process |
| 09/03/2003 | CN1120009C Chinese medicine ÔÇ£Ruan capsuleÔÇØ for treating mastoplasia |
| 09/03/2003 | CN1120008C Method for preparing Chinese medicine for curing epilepsy |
| 09/03/2003 | CN1120007C Medicine for treating mastopathy |
| 09/03/2003 | CN1120003C Water-soluble pearl component and its preparing process |
| 09/03/2003 | CN1119946C Extraction of nutrient from spirulina |
| 09/02/2003 | US6613881 Isolated polypeptide of given amino acid sequence; can use in vaccines |
| 09/02/2003 | US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents |
| 09/02/2003 | US6613568 Exposing a human embryonic stem cell culture to mammalian hematopoietic stromal cells so as to thereby create human hematopoietic cells which are CD34+ |
| 09/02/2003 | US6613566 Platelet suspensions and methods for resuspending platelets |
| 09/02/2003 | US6613563 Viral vectors with modified tropism |
| 09/02/2003 | US6613549 Prevention, therapy intestinal infections |
| 09/02/2003 | US6613544 Osteoprotegerin |
| 09/02/2003 | US6613320 Recombinant CD4+ T cells from an individual afflicted with hyper IgM syndrome transformed with vectors carrying either the wild type or the mutagenized CD40Ls, metabolically radiolabeled, and examined for expression |
| 08/28/2003 | WO2003070933A2 Process of cell electrofusion |
| 08/28/2003 | WO2003070921A1 METHODS FOR PRODUCING Ϝδ T CELLS |
| 08/28/2003 | WO2003070919A1 Antimicrobial composition |
| 08/28/2003 | WO2003070767A1 Tissue specific expression |
| 08/28/2003 | WO2003070291A1 Implant containing cells having growhfactor gene transferred thereinto |
| 08/28/2003 | WO2003070267A1 Enhancing the availability of minerals by using biologically active peptides |
| 08/28/2003 | WO2003070260A1 A photoprotective orally administrable composition for skin |
| 08/28/2003 | WO2003070259A1 Method for treating, preventing, or inhibiting enterotoxigenic escherichia coli infections with bovine erythrocyte preparations |
| 08/28/2003 | WO2003070258A1 Anti-white spot syndrome virus igy |
| 08/28/2003 | WO2003070256A1 Hyaluronic acid mediated adenoviral transduction |
| 08/28/2003 | WO2003070203A1 Orally administrable composition for the photoprotection of the skin |
| 08/28/2003 | WO2003070171A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 08/28/2003 | WO2003070083A2 Endothelial precursor cells for enhancing and restoring vascular function |
| 08/28/2003 | WO2003070019A1 Pet food composition for skin photoprotection |
| 08/28/2003 | WO2003053158A3 Malleable protein matrix and uses thereof |
| 08/28/2003 | WO2003025015A3 A soluble toll-like receptor |
| 08/28/2003 | WO2003012080A3 Ex-vivo selection of t-cells with reduced alloreactivity and use thereof in bone marrow transplantations |
| 08/28/2003 | WO2002102837A3 Marker for identifying hematopoietic stem cells |
| 08/28/2003 | WO2002097044A3 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 08/28/2003 | WO2002088328A3 Method for generating highly active human dendritic cells from monocytes |